Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:15 AM
Ignite Modification Date:
2025-12-25 @ 1:15 AM
NCT ID:
NCT05277493
Eligibility Criteria:
Inclusion Criteria:
* 18 years and older
* newly diagnosed or refractory/relapsed AL amyloidosis
* treated with subcutaneous/intravenous daratumumab alone or subcutaneous/intravenous daratumumab combined with chemotherapy
Exclusion Criteria:
* co-diagnosis of multiple myeloma or Waldenström's macroglobulinemia
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05277493
Study Brief:
Protocol Section:
NCT05277493